Metagenomi Therapeutics (MGX) Current Taxes (2023 - 2024)
Metagenomi Therapeutics (MGX) posted quarterly Current Taxes of $3.3 million for Q1 2024, little changed quarter-over-quarter from $3.3 million in Q4 2023.
Metagenomi Therapeutics (MGX) Current Taxes (2023 - 2024) Analysis & Trends
Metagenomi Therapeutics (MGX) has reported Current Taxes for 2 consecutive years, with $3.3 million the latest figure, recorded in Q1 2024.
- In Q1 2024, Current Taxes changed N/A year-over-year to $3.3 million; the TTM figure through Mar 2024 stood at $3.3 million (changed N/A YoY), while the FY2023 annual figure was $3.3 million, changed N/A from the prior year.
- Current Taxes steadied at $3.3 million in Q1 2024 per MGX's latest filing, from $3.3 million in the prior quarter.
- Across five years, Current Taxes topped out at $3.3 million in Q4 2023 and bottomed at $3.3 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 76.32 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Metagenomi Therapeutics | 46.51 Mn | 46.51 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 3.27 Mn |
| Dec 31, 2023 | 3.27 Mn |